Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBRT and ADT for Localized Prostate Cancer
NCT04489745Phase 2Unknown
- Sponsor
- VA Greater Los Angeles Healthcare System
- Start
- Dec 2016
- Primary completion
- Jan 2022
01
Overview
Phase 2, open-label trial in prostate cancer (PCa), sponsored by VA Greater Los Angeles Healthcare System. Primary endpoint: Progression-Free Survival at 5 years. Status: unknown.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04489745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04489745.